Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP441510.RASRemH3p5GUrI765hVhdPqdO-CWczfaQU2J0Qd-EhzWs130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441510.RASRemH3p5GUrI765hVhdPqdO-CWczfaQU2J0Qd-EhzWs130_provenance.
• NP876618.RAcFtt8fn6WpC5LWfNH-8WMgA6UEWyWrr-XIpB_qwzfqg130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876618.RAcFtt8fn6WpC5LWfNH-8WMgA6UEWyWrr-XIpB_qwzfqg130_provenance.
• NP876670.RARLqtq9fSetYSDwa6g8SKeFg7imBsOUUQkhIDPkPerH4130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876670.RARLqtq9fSetYSDwa6g8SKeFg7imBsOUUQkhIDPkPerH4130_provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP391315.RAd9Q4yTJ7tWg823wVBVHnHZcYq0cVdncCTwaH_IgzjIE130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391315.RAd9Q4yTJ7tWg823wVBVHnHZcYq0cVdncCTwaH_IgzjIE130_provenance.
• NP391316.RAUI7oZTgZTF57f9iE1brcPe6Ai7HObsVYf1v1qyVWpcM130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391316.RAUI7oZTgZTF57f9iE1brcPe6Ai7HObsVYf1v1qyVWpcM130_provenance.
• NP391321.RARD2E64D65rTXplI8i2vSQwd-KTEamZhloF7bpscf-t4130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391321.RARD2E64D65rTXplI8i2vSQwd-KTEamZhloF7bpscf-t4130_provenance.
• NP391322.RAd6WOGdEZC6tSwpthwtiA-1GFQenad22B9o8_uLzGWO8130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391322.RAd6WOGdEZC6tSwpthwtiA-1GFQenad22B9o8_uLzGWO8130_provenance.
• NP810218.RAmEpf4ixtflwSJ6mKC07qoR8f1DpCid_u6liGmnavGZw130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810218.RAmEpf4ixtflwSJ6mKC07qoR8f1DpCid_u6liGmnavGZw130_provenance.
• NP849705.RAu8WIPi3zw832BZs-XVK3blPnQXyZsvI6Qh8-ak32UL0130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849705.RAu8WIPi3zw832BZs-XVK3blPnQXyZsvI6Qh8-ak32UL0130_provenance.
• NP902646.RAt-P4Yy8Fcrh-PnfB-V3Y1V_BK7lx1vt2GWpAOgyWWwY130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902646.RAt-P4Yy8Fcrh-PnfB-V3Y1V_BK7lx1vt2GWpAOgyWWwY130_provenance.
• NP391310.RAmQlpNsogVdHAZR4BqfX8v1mxmDW_y3C6yxt9S0bLR3E130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391310.RAmQlpNsogVdHAZR4BqfX8v1mxmDW_y3C6yxt9S0bLR3E130_provenance.
• NP391314.RAhoU9SCNSNP6zEV05ADANKkG6u6Fi8Qkr3lYb5z8HhNQ130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391314.RAhoU9SCNSNP6zEV05ADANKkG6u6Fi8Qkr3lYb5z8HhNQ130_provenance.
• NP391318.RAmSbI2pA1GZ65DdOvu_IOjkldgc-UrUDs41Hu2xf5SBI130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391318.RAmSbI2pA1GZ65DdOvu_IOjkldgc-UrUDs41Hu2xf5SBI130_provenance.
• NP441589.RAwm7SOJCLSxDA8j8n5CPU8VQqobiVSRpwu18HQubR-Uw130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441589.RAwm7SOJCLSxDA8j8n5CPU8VQqobiVSRpwu18HQubR-Uw130_provenance.
• NP391311.RAIXR_IpSrxfvio-aGE17ra52JhI5gthAnAGwHEIm3Ap0130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391311.RAIXR_IpSrxfvio-aGE17ra52JhI5gthAnAGwHEIm3Ap0130_provenance.
• NP391312.RAPyv2pVQZxYLmk3_KidvWGndu7xB5fbIPeZLxb8bqZTc130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391312.RAPyv2pVQZxYLmk3_KidvWGndu7xB5fbIPeZLxb8bqZTc130_provenance.
• NP810106.RA22ABVLC4PiA7fZ8MWtGqQ919NzPgL_VkQwoMBSoFiIM130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810106.RA22ABVLC4PiA7fZ8MWtGqQ919NzPgL_VkQwoMBSoFiIM130_provenance.
• NP849805.RAzswxYEqJSFHTrxxKN4Z5fNurfwzlUG981pdTnetmkno130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849805.RAzswxYEqJSFHTrxxKN4Z5fNurfwzlUG981pdTnetmkno130_provenance.
• NP902699.RAwl-Qw1-IvXEswcIbuJVkzmFQY1sf7Iui1Ozjp7CtJ1w130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902699.RAwl-Qw1-IvXEswcIbuJVkzmFQY1sf7Iui1Ozjp7CtJ1w130_provenance.
• NP391320.RAx0mizVMRReCeOqfLY8uCiNZ5h9ITaJtxdZaWt9SC0vQ130_assertion description "[We conclude that (1) p62 protein is overexpressed in breast cancer; (2) p62 mRNA and protein increase in response to PSI, with no change of basal promoter activity; (3) PDEF upregulates p62 promoter activity through at least two sites; and (4) PSI downregulates PDEF-induced p62 promoter activation through one of these sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391320.RAx0mizVMRReCeOqfLY8uCiNZ5h9ITaJtxdZaWt9SC0vQ130_provenance.